Comparing liposomal bupivacaine plus bupivacaine to bupivacaine alone in interscalene blocks for rotator cuff repair surgery: a randomized clinical trial
- 21 February 2022
- journal article
- research article
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 47 (5) , 309-312
Abstract
Background Single-injection interscalene brachial plexus blocks are used for analgesia for rotator cuff repair (RCR) but have limited duration. The value of adding liposomal bupivacaine (LB) to prolong single-injection interscalene blocks is unclear. The purpose of this trial is to evaluate the addition of LB to regular bupivacaine interscalene blocks for patients undergoing arthroscopic RCR. Methods In this prospective, randomized trial, 70 patients undergoing primary RCR with equal group allocation were randomized by random number generator to receive an interscalene block with 20 mL of 0.5% bupivacaine or 10 mL 0.5% bupivacaine plus 133 mg LB. The primary outcome was cumulative opioid consumption within 72 hours of the procedure. Secondary outcomes included maximum pain scores and quality of recovery 15 survey scores. Results 70 of the 80 randomized patients were included in final analysis following exclusion for protocol violations and loss to follow-up. Cumulative opioid consumption (oral morphine equivalents) within 72 hours in patients receiving LB was a median (IQR) of 31.9 mg (0, 73.1) compared with 45.0 mg (15.0, 108.8) among patients receiving bupivacaine alone (p=0.312). Patients receiving LB demonstrated mixed results regarding worst pain scores with improvements at 24 hours and 72 hours, but not 48 hours. Conclusions LB added to bupivacaine interscalene blocks does not reduce opioid consumption within 72 hours following arthroscopic RCR. Trial registration number NCT03587584.Keywords
This publication has 15 references indexed in Scilit:
- Perineural Low-Dose Dexamethasone Prolongs Interscalene Block Analgesia With Bupivacaine Compared With Systemic DexamethasoneRegional Anesthesia & Pain Medicine, 2018
- Should continuous rather than single-injection interscalene block be routinely offered for major shoulder surgery? A meta-analysis of the analgesic and side-effects profilesBritish Journal of Anaesthesia, 2018
- Systematic review of the QoR-15 score, a patient- reported outcome measure measuring quality of recovery after surgery and anaesthesiaBritish Journal of Anaesthesia, 2018
- Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom stateBritish Journal of Anaesthesia, 2017
- Evidence basis for using perineural dexmedetomidine to enhance the quality of brachial plexus nerve blocks: a systematic review and meta-analysis of randomized controlled trialsBritish Journal of Anaesthesia, 2017
- Prospective, Randomized Double-Blind StudyRegional Anesthesia & Pain Medicine, 2016
- Will the Real Benefits of Single-Shot Interscalene Block Please Stand Up? A Systematic Review and Meta-AnalysisAnesthesia & Analgesia, 2015
- Dislocation rates of perineural catheters: a volunteer studyBritish Journal of Anaesthesia, 2013
- The Minimum Effective Anesthetic Volume of 0.75% Ropivacaine in Ultrasound-Guided Interscalene Brachial Plexus BlockAnesthesia & Analgesia, 2011
- A Comparison of 0.5% Bupivacaine, 0.5% Ropivacaine, and 0.75% Ropivacaine for Interscalene Brachial Plexus BlockAnesthesia & Analgesia, 1998